Skip to main navigation Skip to search Skip to main content

The PD COMM trial: a protocol for the process evaluation of a randomised trial assessing the effectiveness of two types of SLT for people with Parkinson's disease.

  • Chris Burton
  • , Caroline Rick
  • , P Masterson-Algar
  • , M.C. Brady
  • , A. Nicoll
  • , C.E. Clarke
  • , M. Hughes
  • , P. Au
  • , C.H. Smith
  • , C.M. Sackley

    Research output: Contribution to journalArticle

    7 Citations (Scopus)

    Abstract

    Background: The PD COMM trial is a phase III multi-centre randomised controlled trial whose aim is to evaluate
    the effectiveness and cost-effectiveness of two approaches to speech and language therapy (SLT) compared with
    no SLT intervention (control) for people with Parkinson’s disease who have self-reported or carer-reported problems
    with their speech or voice. Our protocol describes the process evaluation embedded within the outcome evaluation
    whose aim is to evaluate what happened at the time of the PD COMM intervention implementation and to provide
    findings that will assist in the interpretation of the PD COMM trial results. Furthermore, the aim of the PD COMM process
    evaluation is to investigate intervention complexity within a theoretical model of how the trialled interventions might
    work best and why.
    Methods/design: Drawing from the Normalization Process Theory and frameworks for implementation fidelity, a mixed
    method design will be used to address process evaluation research questions. Therapists’ and participants’ perceptions
    and experiences will be investigated via in-depth interviews. Critical incident reports, baseline survey data from therapists,
    treatment record forms and home practice diaries also will be collected at relevant time points throughout the running
    of the PD COMM trial. Process evaluation data will be analysed independently of the outcome evaluation before the two
    sets of data are then combined.
    Discussion: To date, there are a limited number of published process evaluation protocols, and few are linked to trials
    investigating rehabilitation therapies. Providing a strong theoretical framework underpinning design choices and being
    tailored to meet the complex characteristics of the trialled interventions, our process evaluation has the potential to
    provide valuable insight into which components of the interventions being delivered in PD COMM worked best (and
    what did not), how they worked well and why.
    Original languageEnglish
    Pages (from-to)2017
    JournalCurrent Controlled Trials in Cardiovascular Medicine
    Volume18
    Issue number397
    DOIs
    Publication statusPublished - 29 Aug 2017

    Keywords

    • Complex interventions
    • Fidelity
    • Lee Silverman Voice Treatment
    • Process evaluation
    • Speech and language therapy

    Fingerprint

    Dive into the research topics of 'The PD COMM trial: a protocol for the process evaluation of a randomised trial assessing the effectiveness of two types of SLT for people with Parkinson's disease.'. Together they form a unique fingerprint.

    Cite this